Specialties – Page 16

Long COVID in Pregnancy: Assessing Risks for Preterm Birth and Hypertensive Disorders

By MedXY 08/31/2026

This study evaluates the impact of Long COVID on pregnancy outcomes, finding no significant risk for preterm birth but a potential association with hypertensive disorders, underscoring the need for further research.

news OB/GYN & Women's Health

Enhanced Early Detection of Fetal Anomalies: Evaluating the StaFFAUS Protocol in First-Trimester Ultrasound Screening

By MedXY 08/31/2026

The novel StaFFAUS protocol significantly improves early detection and diagnostic performance of fetal structural anomalies in first-trimester ultrasound compared to ISUOG protocols, maintaining clinical feasibility.

Gastroenterology Internal Medicine news

Beyond Cirrhosis: Understanding Major Adverse Liver Outcomes in Alpha-1 Antitrypsin Deficiency Genotypes

By MedXY 08/31/2026

Alpha-1 antitrypsin deficiency (AATD) Z-allele carriers, including heterozygotes and homozygotes, exhibit progressively increased risk of adverse liver outcomes, emphasizing the need for early diagnosis and vigilant monitoring.

Gastroenterology Internal Medicine news

From Pressure Metrics to Personalized Prognosis: Transforming Risk Assessment in Advanced Chronic Liver Disease

By MedXY 08/31/2026

A shift from static portal pressure thresholds to dynamic, non-invasive risk prediction models offers improved prognostic accuracy for decompensation in advanced chronic liver disease, enabling personalized patient management and better clinical outcomes.

Cardiology news

Global Insights on Implantable Cardioverter-Defibrillators in High-Risk Hypertrophic Cardiomyopathy: Efficacy and Outcomes

By MedXY 08/31/2026

An international multicenter study shows ICDs effectively prevent sudden death in high-risk hypertrophic cardiomyopathy patients, demonstrating low mortality rates and significant lifesaving interventions over long-term follow-up.

Gastroenterology news Oncology

Targeting the CA19-9 Glycan: A Promising CAR T Cell Therapy for Pancreatic and Gastrointestinal Cancers

By MedXY 08/30/2026

CAR T cells targeting the CA19-9 glycan show potent, specific anti-tumor activity in pancreatic and various gastrointestinal cancers, providing new avenues for immunotherapy of hard-to-treat solid tumors.

Hematology-Oncology Neurology news

Recent Mechanical Venous Thrombosis Risk Factors and Their Role in Young-Onset Cryptogenic Ischemic Stroke

By MedXY 08/30/2026

This multicenter study reveals that recent mechanical venous thrombosis risk factors within 14 days significantly increase the risk of cryptogenic ischemic stroke in young adults, notably in those under 40 and with patent foramen ovale, independent of thrombophilia markers.

Cardiology Neurology news

RNF213 p.R4810K Variant: A Novel Independent Genetic Risk Factor for Extracranial Carotid Artery Disease

By MedXY 08/30/2026

The RNF213 p.R4810K variant independently increases risk and severity of extracranial carotid artery disease, distinct from its known association with intracranial atherosclerosis, highlighting new insights into vascular disease genetics and stroke risk assessment.

Neurology news Radiology

Unraveling White Matter Hyperintensities: Distinct Lesion Subtypes Reveal Diverse Clinical Implications Beyond Location

By MedXY 08/30/2026

Advanced MRI analyses identify three biologically distinct subtypes of white matter hyperintensities (WMHs), linking specific lesion evolution patterns with neurodegeneration and vascular/metabolic risks, offering refined insights into cerebrovascular contributions to aging and neurodegenerative diseases.

Neurology news

Severe Parsonage-Turner Syndrome vs. Traumatic Brachial Plexopathy: Insights into Motor Recovery and Treatment Outcomes

By MedXY 08/30/2026

This study compares motor-unit reinnervation and functional recovery in severe Parsonage-Turner syndrome and surgically managed traumatic brachial plexopathy, highlighting spontaneous recovery in PTS and benefits of early reconstruction in TBP.

Diabetes & Endocrinology news Pathology & Lab Medicine

Refining Risk Stratification in Indeterminate Thyroid Nodules: The Role of Afirma Xpression Atlas Alteration Status

By MedXY 08/30/2026

Detection of genomic alterations via Afirma Xpression Atlas in indeterminate thyroid nodules enhances malignancy risk stratification beyond Afirma GSC results, guiding surgical decision-making.

Diabetes & Endocrinology news Pathology & Lab Medicine/Bệnh học

Enhanced Diagnosis of Primary Aldosteronism: Comparing LC-MS/MS and Immunoassay for Urinary Aldosterone Measurement

By MedXY 08/30/2026

This study demonstrates that urinary aldosterone measurement by LC-MS/MS outperforms immunoassay in diagnosing primary aldosteronism, especially when urinary sodium is within an optimal range, offering improved sensitivity and specificity for clinical use.

Diabetes & Endocrinology Gastroenterology news

Comparative Impacts of Semaglutide and Bariatric Surgery on Hepatic Steatosis and Fibrosis in Obese Patients with MASLD

By MedXY 08/30/2026

This prospective cohort study compares semaglutide, bariatric surgery, and lifestyle therapy in obese patients with MASLD, demonstrating semaglutide and surgery improve liver steatosis and fibrosis markers better than lifestyle changes alone, with semaglutide showing weight-independent benefits.

Diabetes & Endocrinology Internal Medicine news

Impact of the DASH4D Diet on Glycemic Biomarkers in Adults with Type 2 Diabetes: Insights from a Randomized Controlled Feeding Trial

By MedXY 08/30/2026

The DASH4D diet, a tailored DASH-style intervention for diabetes, significantly improved key glycemic biomarkers including fructosamine, fasting glucose, and HbA1c compared to a typical American diet in adults with type 2 diabetes.

Diabetes & Endocrinology news

Optimizing Capillary Ketone Testing Frequency to Predict Short-Term Diabetic Ketoacidosis Risk in Type 1 Diabetes

By MedXY 08/30/2026

Weekly well-day capillary ketone testing maintains predictive accuracy for 1-month diabetic ketoacidosis risk, offering a practical and less burdensome monitoring strategy for patients with type 1 diabetes.

AI Cardiology news

Revolutionizing Aortic Stenosis Screening: AI-Enabled Focused Cardiac Ultrasound with Novice Operators

By MedXY 08/30/2026

A novel deep learning algorithm accurately detects moderate or greater aortic stenosis using AI-guided focused cardiac ultrasound acquired by novice operators, presenting a scalable solution to expand screening accessibility.

Cardiology news

Advancing Prognostication in Transthyretin Amyloid Cardiomyopathy: A Machine Learning Risk Prediction Model

By MedXY 08/30/2026

A novel machine learning-based model demonstrates improved risk prediction in transthyretin amyloid cardiomyopathy, surpassing traditional staging systems and supporting personalized patient management.

Cardiology news

Evolving Impact of Implantable Cardioverter-Defibrillators on Mortality Post-Myocardial Infarction: Insights from the PROFID Study

By MedXY 08/30/2026

The PROFID study reveals a declining mortality benefit from primary prevention implantable cardioverter-defibrillators in post-myocardial infarction patients with reduced ejection fraction over recent decades, highlighting changing clinical landscapes.

Cardiology news

Bridging the Gap: ESC Prevention and Cardiac Rehabilitation Recommendations and What EUROASPIRE VI Reveals About Reality in Europe

By MedXY 08/30/2026

EUROASPIRE VI exposes wide gaps between ESC prevention and cardiac rehabilitation recommendations and everyday care across Europe — especially in high-risk regions. This article distills core guideline recommendations, what's new, and how clinicians and systems can close the gap.

Cardiology news

Sustained Cardiovascular Protection With Evolocumab in Patients Without Prior MI or Stroke: Insights From the VESALIUS-CV Trial

By MedXY 08/30/2026

Evolocumab significantly reduces first and subsequent major adverse cardiovascular events in high-risk patients without prior myocardial infarction or stroke, affirming the benefit of intensive LDL-C lowering for cumulative cardiovascular risk reduction.